Author

Kyle E. Evans

Harvard UniversityORCID 0000-0002-6246-9520Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Artem SokoloviD· 1 shared Bradley T. HymaniD· 1 shared Clemens B. HugiD· 1 shared George ZhouiD· 1 shared Mark W. AlbersiD· 1 shared Nathan T. JohnsoniD· 1 shared Nienke MoretiD· 1 shared Petar V. TodoroviD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Artem SokolovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeuroscienceNature CommunicationsPeer-reviewedFeb 15, 2021

Machine Learning Identifies Novel Candidates for DrugRepurposing in Alzheimer's Disease

Steve Rodriguez, Clemens B. Hug, Petar V. Todorov…·Artem Sokolov

The paper presents a machine learning framework to identify FDA-approved drugs for repurposing in Alzheimer's Disease by analyzing gene lists associated with disease severity and molecular mechanisms.

299 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky